SCHEDULE: FMR LLC Discloses 7% Stake in Solid Biosciences

FMR LLC, along with Abigail P. Johnson, has reported a beneficial ownership of 7.0% in Solid Biosciences Inc.'s common stock as of June 30, 2026.

Summary

• FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, indicating their beneficial ownership of Solid Biosciences Inc. common stock.
• As of June 30, 2026, the aggregate amount beneficially owned is 6,875,956.68 shares.
• This represents 7.0% of the class of securities.
• FMR LLC has sole voting power for 6,875,423 shares and sole dispositive power for 6,875,956.68 shares.
• Abigail P. Johnson has sole dispositive power for 6,875,956.68 shares.
• The filing is made under Rule 13d-1(b), classifying FMR LLC as an investment adviser.
• The filing confirms that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a neutral to slightly negative sentiment due to its nature as a Schedule 13G, indicating a passive ownership stake rather than active company performance or strategic shifts.

Positives

• Significant institutional ownership by FMR LLC and Abigail P. Johnson, which can signal confidence in the company's long-term prospects.
• The filing confirms that the ownership stake is held in the ordinary course of business, suggesting a passive investment strategy rather than an attempt at control.

Negatives

• The filing is a Schedule 13G, which typically indicates a passive investment and does not provide insights into the company's operational performance or strategic direction.
• No new information regarding company performance, financials, or future plans is disclosed in this filing.

Risks

• The passive nature of the ownership reported in a 13G filing means that changes in this stake could occur without prior notice, potentially impacting share price.
• While not explicitly stated as a risk in this filing, significant ownership by a large entity like FMR LLC could lead to future strategic shifts if their investment thesis changes.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding Solid Biosciences Inc.'s future performance. It solely reports on beneficial ownership.

Management Comments

• FMR LLC and Abigail P. Johnson certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for large institutional investors like FMR LLC, indicating a passive investment approach. This filing does not provide insights into Solid Biosciences' specific performance within the biotechnology sector, but rather reflects the investment holdings of a major financial entity.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by FMR LLC may be viewed positively, indicating institutional support, but the passive nature of the filing offers no direct operational impact.
• Management: The filing confirms that the ownership is not intended to influence control, which is a standard certification for passive investors.

Next Steps

• FMR LLC and Abigail P. Johnson will continue to hold their beneficial ownership stake in Solid Biosciences Inc.
• Future changes in ownership will be reported via subsequent filings if thresholds are met.

Key Dates

Keywords

Solid Biosciences, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Investment Adviser